de la Mata M, Rufián S, Gómez F, Varo E, López-Cillero P, Costán G, Solórzano G, González R, Miño G, Pera C
Liver Transplant Unit, Reina Sofía Hospital, University of Cordoba, Spain.
J Clin Gastroenterol. 1994 Oct;19(3):238-41. doi: 10.1097/00004836-199410000-00015.
We report a 44-year-old man who received a liver graft because of fulminant liver failure due to hepatitis B virus. Nine months later a new episode of acute hepatitis B followed a fulminant course and led to another transplantation. The patient died due to invasive aspergillosis and multiorgan failure 3 weeks after the second transplant. This case reveals that hepatitis B virus reinfection may also occur after transplantation in patients with fulminant hepatitis B and under immunosuppression circumstances. Although immunoprophylaxis with hepatitis B hyperimmune globulin may prevent hepatitis B reinfection, it does not guarantee complete protection even in patients presumed to have low risk of reinfection. Finally, this case confirms the high risk of fungal infections in patients with fulminant liver failure and the need to establish early antifungal therapy.
我们报告一名44岁男性,其因乙型肝炎病毒导致暴发性肝衰竭而接受肝移植。九个月后,新的急性乙型肝炎发作,呈暴发性病程,导致再次移植。患者在第二次移植后3周因侵袭性曲霉病和多器官衰竭死亡。该病例表明,暴发性乙型肝炎患者在移植后且处于免疫抑制状态下也可能发生乙型肝炎病毒再感染。尽管使用乙型肝炎高效价免疫球蛋白进行免疫预防可能预防乙型肝炎再感染,但即使在假定再感染风险较低的患者中,也不能保证完全保护。最后,该病例证实了暴发性肝衰竭患者发生真菌感染的高风险以及早期抗真菌治疗的必要性。